| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 9.92e-07 | 14 | 29 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 2.03e-05 | 5 | 29 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.01e-05 | 46 | 29 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.51e-04 | 129 | 29 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 9.23e-04 | 31 | 29 | 2 | GO:0051393 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.34e-03 | 151 | 29 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.37e-03 | 152 | 29 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | actinin binding | 1.77e-03 | 43 | 29 | 2 | GO:0042805 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.29e-03 | 182 | 29 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.36e-03 | 184 | 29 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.42e-03 | 230 | 29 | 3 | GO:0005516 | |
| GeneOntologyBiologicalProcess | calcium ion import | 7.73e-06 | 98 | 27 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.65e-05 | 5 | 27 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 2.06e-05 | 41 | 27 | 3 | GO:0086091 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 2.29e-05 | 129 | 27 | 4 | GO:0002027 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 3.33e-05 | 48 | 27 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 3.33e-05 | 48 | 27 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 4.47e-05 | 153 | 27 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 6.19e-05 | 59 | 27 | 3 | GO:0086065 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle contraction | 6.19e-05 | 59 | 27 | 3 | GO:0045933 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 7.19e-05 | 62 | 27 | 3 | GO:0086002 | |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell action potential | 1.08e-04 | 12 | 27 | 2 | GO:0098911 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 1.31e-04 | 202 | 27 | 4 | GO:0006937 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.52e-04 | 400 | 27 | 5 | GO:0006936 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.73e-04 | 217 | 27 | 4 | GO:0006941 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.73e-04 | 217 | 27 | 4 | GO:0097553 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 1.96e-04 | 16 | 27 | 2 | GO:1904181 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.97e-04 | 87 | 27 | 3 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 2.40e-04 | 93 | 27 | 3 | GO:0086003 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 2.92e-04 | 249 | 27 | 4 | GO:0008016 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 2.97e-04 | 100 | 27 | 3 | GO:0061337 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 3.75e-04 | 22 | 27 | 2 | GO:1902514 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 4.10e-04 | 23 | 27 | 2 | GO:0086012 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport via high voltage-gated calcium channel | 4.10e-04 | 23 | 27 | 2 | GO:0061577 | |
| GeneOntologyBiologicalProcess | insulin secretion | 4.20e-04 | 274 | 27 | 4 | GO:0030073 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 4.62e-04 | 509 | 27 | 5 | GO:0006816 | |
| GeneOntologyBiologicalProcess | positive regulation of insulin secretion | 5.07e-04 | 120 | 27 | 3 | GO:0032024 | |
| GeneOntologyBiologicalProcess | heart contraction | 5.77e-04 | 298 | 27 | 4 | GO:0060047 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.98e-04 | 127 | 27 | 3 | GO:0070252 | |
| GeneOntologyBiologicalProcess | muscle system process | 6.41e-04 | 547 | 27 | 5 | GO:0003012 | |
| GeneOntologyBiologicalProcess | heart process | 6.60e-04 | 309 | 27 | 4 | GO:0003015 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 7.02e-04 | 30 | 27 | 2 | GO:0098901 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 7.27e-04 | 317 | 27 | 4 | GO:0090257 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 7.79e-04 | 323 | 27 | 4 | GO:0051924 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 8.07e-04 | 326 | 27 | 4 | GO:1903522 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 8.28e-04 | 142 | 27 | 3 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 8.28e-04 | 142 | 27 | 3 | GO:0098659 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 8.83e-04 | 334 | 27 | 4 | GO:0030072 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 8.97e-04 | 146 | 27 | 3 | GO:0051209 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 9.02e-04 | 34 | 27 | 2 | GO:0086019 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 9.15e-04 | 147 | 27 | 3 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 9.52e-04 | 149 | 27 | 3 | GO:0051282 | |
| GeneOntologyBiologicalProcess | peptide secretion | 9.75e-04 | 343 | 27 | 4 | GO:0002790 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.01e-03 | 36 | 27 | 2 | GO:0086010 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.03e-03 | 153 | 27 | 3 | GO:0051208 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 1.07e-03 | 37 | 27 | 2 | GO:0086005 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide hormone secretion | 1.11e-03 | 157 | 27 | 3 | GO:0090277 | |
| GeneOntologyBiologicalProcess | peptide transport | 1.11e-03 | 355 | 27 | 4 | GO:0015833 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide secretion | 1.19e-03 | 161 | 27 | 3 | GO:0002793 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 1.25e-03 | 40 | 27 | 2 | GO:0045762 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 1.32e-03 | 167 | 27 | 3 | GO:0060048 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell contraction | 1.44e-03 | 43 | 27 | 2 | GO:0086004 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.59e-03 | 392 | 27 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 1.79e-03 | 48 | 27 | 2 | GO:0031281 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 1.87e-03 | 49 | 27 | 2 | GO:0051349 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 2.03e-03 | 194 | 27 | 3 | GO:0050714 | |
| GeneOntologyBiologicalProcess | hormone secretion | 2.05e-03 | 420 | 27 | 4 | GO:0046879 | |
| GeneOntologyBiologicalProcess | amide transport | 2.05e-03 | 420 | 27 | 4 | GO:0042886 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 2.16e-03 | 426 | 27 | 4 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based movement | 2.18e-03 | 53 | 27 | 2 | GO:1903115 | |
| GeneOntologyBiologicalProcess | action potential | 2.24e-03 | 201 | 27 | 3 | GO:0001508 | |
| GeneOntologyBiologicalProcess | hormone transport | 2.27e-03 | 432 | 27 | 4 | GO:0009914 | |
| GeneOntologyBiologicalProcess | regulation of system process | 2.37e-03 | 734 | 27 | 5 | GO:0044057 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone secretion | 2.37e-03 | 205 | 27 | 3 | GO:0046887 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 2.70e-03 | 59 | 27 | 2 | GO:0045761 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transport | 2.82e-03 | 218 | 27 | 3 | GO:1903169 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 2.88e-03 | 61 | 27 | 2 | GO:0003254 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 3.29e-03 | 230 | 27 | 3 | GO:0098739 | |
| GeneOntologyBiologicalProcess | protein secretion | 3.32e-03 | 480 | 27 | 4 | GO:0009306 | |
| GeneOntologyBiologicalProcess | eye development | 3.32e-03 | 480 | 27 | 4 | GO:0001654 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion | 3.33e-03 | 231 | 27 | 3 | GO:0050796 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | 3.40e-03 | 483 | 27 | 4 | GO:0035592 | |
| GeneOntologyBiologicalProcess | visual system development | 3.40e-03 | 483 | 27 | 4 | GO:0150063 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | 3.58e-03 | 490 | 27 | 4 | GO:0071692 | |
| GeneOntologyBiologicalProcess | sensory system development | 3.60e-03 | 491 | 27 | 4 | GO:0048880 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 3.66e-03 | 493 | 27 | 4 | GO:0010959 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 3.67e-03 | 69 | 27 | 2 | GO:0031279 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 4.10e-03 | 73 | 27 | 2 | GO:0051339 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transporter activity | 4.43e-03 | 256 | 27 | 3 | GO:0032412 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 4.58e-03 | 259 | 27 | 3 | GO:0051651 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 4.70e-07 | 12 | 28 | 3 | GO:1990454 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.14e-05 | 46 | 28 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.26e-04 | 73 | 28 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | T-tubule | 1.59e-04 | 79 | 28 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.81e-04 | 277 | 28 | 4 | GO:0042734 | |
| GeneOntologyCellularComponent | dendrite | 8.15e-04 | 858 | 28 | 6 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 8.25e-04 | 860 | 28 | 6 | GO:0097447 | |
| GeneOntologyCellularComponent | I band | 1.39e-03 | 166 | 28 | 3 | GO:0031674 | |
| GeneOntologyCellularComponent | sarcolemma | 2.05e-03 | 190 | 28 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | cation channel complex | 3.73e-03 | 235 | 28 | 3 | GO:0034703 | |
| Domain | VDCC_L_a1su | 1.34e-08 | 4 | 29 | 3 | IPR005446 | |
| Domain | GPHH_dom | 1.17e-07 | 7 | 29 | 3 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 1.17e-07 | 7 | 29 | 3 | IPR014873 | |
| Domain | Ca_chan_IQ | 1.17e-07 | 7 | 29 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 1.17e-07 | 7 | 29 | 3 | PF08763 | |
| Domain | GPHH | 1.17e-07 | 7 | 29 | 3 | PF16905 | |
| Domain | VDCCAlpha1 | 4.01e-07 | 10 | 29 | 3 | IPR002077 | |
| Domain | CAC1F_C | 6.98e-06 | 3 | 29 | 2 | PF16885 | |
| Domain | CAC1F_C | 6.98e-06 | 3 | 29 | 2 | IPR031688 | |
| Domain | Channel_four-helix_dom | 9.31e-05 | 57 | 29 | 3 | IPR027359 | |
| Domain | - | 9.31e-05 | 57 | 29 | 3 | 1.20.120.350 | |
| Domain | - | 5.24e-04 | 679 | 29 | 6 | 3.30.160.60 | |
| Domain | zf-C2H2 | 5.84e-04 | 693 | 29 | 6 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 5.89e-04 | 694 | 29 | 6 | IPR013087 | |
| Domain | tRNA-bd_arm | 6.29e-04 | 24 | 29 | 2 | IPR010978 | |
| Domain | Ion_trans_dom | 7.21e-04 | 114 | 29 | 3 | IPR005821 | |
| Domain | Ion_trans | 7.21e-04 | 114 | 29 | 3 | PF00520 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.05e-03 | 775 | 29 | 6 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.06e-03 | 777 | 29 | 6 | PS00028 | |
| Domain | Znf_C2H2-like | 1.20e-03 | 796 | 29 | 6 | IPR015880 | |
| Domain | Znf_C2H2 | 1.28e-03 | 805 | 29 | 6 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.30e-03 | 808 | 29 | 6 | SM00355 | |
| Domain | zf-C2H2_6 | 1.24e-02 | 314 | 29 | 3 | PF13912 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 4.87e-08 | 6 | 20 | 3 | M47762 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 8.80e-07 | 14 | 20 | 3 | M47692 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 3.18e-06 | 74 | 20 | 4 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 3.18e-06 | 74 | 20 | 4 | M16376 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 4.25e-06 | 23 | 20 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 5.51e-06 | 25 | 20 | 3 | M47948 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.71e-05 | 42 | 20 | 3 | M7169 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.83e-05 | 147 | 20 | 4 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.36e-05 | 151 | 20 | 4 | M39329 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.19e-05 | 63 | 20 | 3 | M11187 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.02e-04 | 178 | 20 | 4 | M2890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.04e-04 | 11 | 20 | 2 | M47958 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.48e-04 | 74 | 20 | 3 | MM15962 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.74e-04 | 78 | 20 | 3 | M1921 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.80e-04 | 79 | 20 | 3 | M17673 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 2.09e-04 | 83 | 20 | 3 | M8728 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 2.65e-04 | 90 | 20 | 3 | M835 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 3.72e-04 | 101 | 20 | 3 | M1979 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 4.53e-04 | 108 | 20 | 3 | M17034 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 5.45e-04 | 115 | 20 | 3 | M9387 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 7.07e-04 | 28 | 20 | 2 | M10679 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 1.58e-03 | 166 | 20 | 3 | M16024 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 1.99e-03 | 47 | 20 | 2 | M19708 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.33e-03 | 61 | 20 | 2 | MM15071 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 4.61e-03 | 72 | 20 | 2 | MM14631 | |
| Pathway | WP_MAPK_SIGNALING | 4.80e-03 | 246 | 20 | 3 | M39597 | |
| Pathway | WP_JOUBERT_SYNDROME | 5.12e-03 | 76 | 20 | 2 | M39835 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 5.66e-03 | 261 | 20 | 3 | M42565 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 6.03e-03 | 267 | 20 | 3 | M10792 | |
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 17289261 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 17767505 | ||
| Pubmed | 5.79e-10 | 3 | 30 | 3 | 2173707 | ||
| Pubmed | 2.32e-09 | 4 | 30 | 3 | 20937870 | ||
| Pubmed | 2.02e-08 | 7 | 30 | 3 | 12900400 | ||
| Pubmed | 2.62e-07 | 15 | 30 | 3 | 20188150 | ||
| Pubmed | 2.62e-07 | 15 | 30 | 3 | 24453333 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24849370 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25277766 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 20014384 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 7.19e-07 | 2 | 30 | 2 | 26049024 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 7635187 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17015854 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 30001160 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 7.19e-07 | 2 | 30 | 2 | 16706838 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21789999 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 23761887 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 14981074 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21352396 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 7.19e-07 | 2 | 30 | 2 | 25292336 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 1281468 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 17526649 | ||
| Pubmed | Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. | 7.19e-07 | 2 | 30 | 2 | 28978442 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 7.19e-07 | 2 | 30 | 2 | 24941892 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 21054386 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 7.19e-07 | 2 | 30 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 7.19e-07 | 2 | 30 | 2 | 16267232 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24848473 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 22826131 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24996399 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24470632 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24760982 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 24086669 | ||
| Pubmed | Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels. | 2.16e-06 | 3 | 30 | 2 | 9668070 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 19351867 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 2.16e-06 | 3 | 30 | 2 | 21832054 | |
| Pubmed | Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure. | 2.16e-06 | 3 | 30 | 2 | 23973784 | |
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26831068 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 31302118 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23045342 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 23338940 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 11206130 | ||
| Pubmed | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. | 2.16e-06 | 3 | 30 | 2 | 24934288 | |
| Pubmed | mRNA for cardiac calcium channel is expressed during development of skeletal muscle. | 2.16e-06 | 3 | 30 | 2 | 8381753 | |
| Pubmed | Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. | 4.31e-06 | 4 | 30 | 2 | 17110593 | |
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 31663850 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 11296258 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 1335956 | ||
| Pubmed | 7.18e-06 | 5 | 30 | 2 | 15451373 | ||
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 1.08e-05 | 6 | 30 | 2 | 16029198 | |
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 21224388 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 23734214 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 9004034 | ||
| Pubmed | 2.01e-05 | 8 | 30 | 2 | 28330839 | ||
| Pubmed | 2.47e-05 | 1049 | 30 | 7 | 27880917 | ||
| Pubmed | 2.58e-05 | 9 | 30 | 2 | 16382099 | ||
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 2.67e-05 | 67 | 30 | 3 | 16987237 | |
| Pubmed | 3.94e-05 | 11 | 30 | 2 | 18809727 | ||
| Pubmed | 8.57e-05 | 16 | 30 | 2 | 32994313 | ||
| Pubmed | Novel cDNA clones obtained by antibody screening of a mouse cerebellar cDNA expression library. | 9.70e-05 | 17 | 30 | 2 | 7808216 | |
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 9.70e-05 | 17 | 30 | 2 | 27725084 | |
| Pubmed | Inhibition of a transcriptional repressor rescues hearing in a splicing factor-deficient mouse. | 1.09e-04 | 18 | 30 | 2 | 33087486 | |
| Pubmed | 1.41e-04 | 117 | 30 | 3 | 12107410 | ||
| Pubmed | Genome-wide association study identifies five new schizophrenia loci. | 1.80e-04 | 23 | 30 | 2 | 21926974 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.34e-04 | 139 | 30 | 3 | 16985003 | |
| Pubmed | 2.55e-04 | 143 | 30 | 3 | 20424473 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 3.74e-04 | 33 | 30 | 2 | 22357600 | |
| Pubmed | 4.16e-04 | 169 | 30 | 3 | 31462741 | ||
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 4.96e-04 | 38 | 30 | 2 | 36674791 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.96e-04 | 38 | 30 | 2 | 30786075 | |
| Pubmed | 6.15e-04 | 457 | 30 | 4 | 22190034 | ||
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 6.65e-04 | 44 | 30 | 2 | 27534441 | |
| Pubmed | 6.96e-04 | 45 | 30 | 2 | 25979088 | ||
| Pubmed | 7.45e-04 | 481 | 30 | 4 | 28190767 | ||
| GeneFamily | Calcium voltage-gated channel subunits | 5.95e-06 | 26 | 25 | 3 | 253 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.56e-04 | 718 | 25 | 6 | 28 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 5.11e-06 | 223 | 30 | 5 | M17621 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-07 | 198 | 30 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.08e-06 | 192 | 30 | 4 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.76e-06 | 196 | 30 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-06 | 198 | 30 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.12e-06 | 198 | 30 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 9.30e-06 | 199 | 30 | 4 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 9.49e-06 | 200 | 30 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 166 | 30 | 3 | c11dcf9705b85ac3da6ae86358f5ffd64ae8327e | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 172 | 30 | 3 | 24ecfda5e43e28f190089770cd2eae5bf2ed292b | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 172 | 30 | 3 | db5a31cafce4346fe459d7f35210823fd7004439 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 178 | 30 | 3 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.32e-04 | 179 | 30 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 179 | 30 | 3 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-04 | 181 | 30 | 3 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 2.40e-04 | 181 | 30 | 3 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 2.44e-04 | 182 | 30 | 3 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-04 | 183 | 30 | 3 | 6e5b39c0170d62eb7fdd411dcfff51ed176573d0 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.48e-04 | 183 | 30 | 3 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-04 | 183 | 30 | 3 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.60e-04 | 186 | 30 | 3 | 1587667e5084ac43505d027af925ba711e228150 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.64e-04 | 187 | 30 | 3 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.64e-04 | 187 | 30 | 3 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.64e-04 | 187 | 30 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.68e-04 | 188 | 30 | 3 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.77e-04 | 190 | 30 | 3 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.77e-04 | 190 | 30 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-04 | 190 | 30 | 3 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-04 | 191 | 30 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.81e-04 | 191 | 30 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.85e-04 | 192 | 30 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 192 | 30 | 3 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.90e-04 | 193 | 30 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.90e-04 | 193 | 30 | 3 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-04 | 193 | 30 | 3 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-04 | 193 | 30 | 3 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.90e-04 | 193 | 30 | 3 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.94e-04 | 194 | 30 | 3 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.94e-04 | 194 | 30 | 3 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.94e-04 | 194 | 30 | 3 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.94e-04 | 194 | 30 | 3 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.99e-04 | 195 | 30 | 3 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.99e-04 | 195 | 30 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.99e-04 | 195 | 30 | 3 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-04 | 195 | 30 | 3 | d35102f95bb1e419d2df05ff0a01b6c5c923acef | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 195 | 30 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 195 | 30 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.99e-04 | 195 | 30 | 3 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-04 | 196 | 30 | 3 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.03e-04 | 196 | 30 | 3 | 547901c7a665770eff78eede69b8625b416c8186 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.03e-04 | 196 | 30 | 3 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.03e-04 | 196 | 30 | 3 | 6e08d7ba67da161c2dca1a17c440ffb9d9b5bc3b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.03e-04 | 196 | 30 | 3 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.08e-04 | 197 | 30 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 3.08e-04 | 197 | 30 | 3 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.08e-04 | 197 | 30 | 3 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.08e-04 | 197 | 30 | 3 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.08e-04 | 197 | 30 | 3 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.12e-04 | 198 | 30 | 3 | eda85a592527992b51a00f288cff0c3239c47e6f | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.12e-04 | 198 | 30 | 3 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.12e-04 | 198 | 30 | 3 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.12e-04 | 198 | 30 | 3 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.12e-04 | 198 | 30 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.12e-04 | 198 | 30 | 3 | 84697f316d9195ebe838cf57f4dbdd9feea43bec | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.12e-04 | 198 | 30 | 3 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.12e-04 | 198 | 30 | 3 | 9b1a58fcf818f9c4ae57bbe99655f0a64fe87df7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.12e-04 | 198 | 30 | 3 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.17e-04 | 199 | 30 | 3 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.17e-04 | 199 | 30 | 3 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-04 | 200 | 30 | 3 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.22e-04 | 200 | 30 | 3 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.22e-04 | 200 | 30 | 3 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 3.22e-04 | 200 | 30 | 3 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.22e-04 | 200 | 30 | 3 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.22e-04 | 200 | 30 | 3 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| Drug | Nilvadipine | 2.06e-08 | 5 | 30 | 3 | DB06712 | |
| Drug | Nisoldipine | 2.06e-08 | 5 | 30 | 3 | DB00401 | |
| Drug | CPU-23 | 4.12e-08 | 6 | 30 | 3 | CID003036051 | |
| Drug | Amlodipine | 7.20e-08 | 7 | 30 | 3 | DB00381 | |
| Drug | Isradipine | 7.20e-08 | 7 | 30 | 3 | DB00270 | |
| Drug | Nitrendipine | 1.15e-07 | 8 | 30 | 3 | DB01054 | |
| Drug | Nifedipine | 1.15e-07 | 8 | 30 | 3 | DB01115 | |
| Drug | Cinnarizine | 1.72e-07 | 9 | 30 | 3 | DB00568 | |
| Drug | Nimodipine | 1.72e-07 | 9 | 30 | 3 | DB00393 | |
| Drug | Felodipine | 3.38e-07 | 11 | 30 | 3 | DB01023 | |
| Drug | Mibefradil | 3.38e-07 | 11 | 30 | 3 | DB01388 | |
| Drug | AC1L1JG6 | 7.44e-07 | 14 | 30 | 3 | CID000005026 | |
| Drug | Nicardipine | 7.44e-07 | 14 | 30 | 3 | DB00622 | |
| Drug | FPL 64176 | 9.29e-07 | 15 | 30 | 3 | CID000003423 | |
| Drug | Verapamil | 1.14e-06 | 16 | 30 | 3 | DB00661 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 3.43e-06 | 79 | 30 | 4 | CID005287890 | |
| Drug | NSC-686960 | 1.01e-05 | 4 | 30 | 2 | CID000192816 | |
| Drug | CNS 1145 | 1.10e-05 | 33 | 30 | 3 | CID000190902 | |
| Drug | IHC-64 | 1.10e-05 | 33 | 30 | 3 | CID000162753 | |
| Drug | methyl beta-aminocrotonate | 1.67e-05 | 5 | 30 | 2 | CID000084253 | |
| Drug | nemadipine-A | 1.67e-05 | 5 | 30 | 2 | CID002856102 | |
| Drug | B 874-67 | 1.67e-05 | 5 | 30 | 2 | CID000195466 | |
| Drug | pimozide | 2.26e-05 | 127 | 30 | 4 | CID000016362 | |
| Drug | Magnesium Sulfate | 2.51e-05 | 6 | 30 | 2 | DB00653 | |
| Drug | h PM | 2.82e-05 | 45 | 30 | 3 | CID005494424 | |
| Drug | KW-3049 | 3.88e-05 | 50 | 30 | 3 | CID000002324 | |
| Drug | 1,5-benzothiazepin-4(5H)-one | 4.68e-05 | 8 | 30 | 2 | CID000358939 | |
| Drug | Cinildipine | 5.46e-05 | 56 | 30 | 3 | CID000002752 | |
| Drug | nilvadipine | 6.71e-05 | 60 | 30 | 3 | CID000004494 | |
| Drug | IAA-94 | 7.06e-05 | 61 | 30 | 3 | CID000003667 | |
| Drug | AC1L3TPS | 7.50e-05 | 10 | 30 | 2 | CID000121952 | |
| Drug | lercanidipine | 7.77e-05 | 63 | 30 | 3 | CID000065866 | |
| Drug | NSC759256 | 7.77e-05 | 63 | 30 | 3 | CID000125889 | |
| Drug | mibefradil | 8.15e-05 | 64 | 30 | 3 | CID000060662 | |
| Drug | gallopamil | 9.34e-05 | 67 | 30 | 3 | CID000001234 | |
| Drug | AC1L2AC7 | 1.02e-04 | 69 | 30 | 3 | CID000068733 | |
| Drug | AC1L1JVU | 1.16e-04 | 72 | 30 | 3 | CID000005229 | |
| Drug | CAS 298-57-7 | 1.21e-04 | 73 | 30 | 3 | CID000002761 | |
| Drug | ethosuximide | 1.26e-04 | 74 | 30 | 3 | CID000003291 | |
| Drug | nisoldipine | 1.47e-04 | 78 | 30 | 3 | CID000004499 | |
| Drug | pinaverium bromide | 1.51e-04 | 14 | 30 | 2 | CID000040703 | |
| Drug | fendiline | 1.99e-04 | 16 | 30 | 2 | CID000003336 | |
| Drug | efonidipine | 2.25e-04 | 17 | 30 | 2 | CID000119170 | |
| Drug | AC1NUZ8M | 2.40e-04 | 92 | 30 | 3 | CID000073211 | |
| Drug | manidipine | 2.63e-04 | 95 | 30 | 3 | CID000004008 | |
| Drug | isotetrandrine | 2.80e-04 | 97 | 30 | 3 | CID000005422 | |
| Drug | nitrendipine | 2.89e-04 | 98 | 30 | 3 | CID000004507 | |
| Drug | isradipine | 3.06e-04 | 100 | 30 | 3 | CID000003784 | |
| Drug | clevidipine | 3.14e-04 | 20 | 30 | 2 | CID000153994 | |
| Drug | loperamide | 3.53e-04 | 105 | 30 | 3 | CID000003954 | |
| Drug | pyraclofos | 3.63e-04 | 106 | 30 | 3 | CID000093460 | |
| Drug | verapamil | 4.13e-04 | 490 | 30 | 5 | CID000002520 | |
| Drug | YM-09730-5 | 4.17e-04 | 23 | 30 | 2 | CID000002296 | |
| Drug | lamotrigine | 4.73e-04 | 116 | 30 | 3 | CID000003878 | |
| Drug | AC1NBU2S | 4.85e-04 | 117 | 30 | 3 | CID004473765 | |
| Drug | MgSO4.7H2O | 4.94e-04 | 25 | 30 | 2 | CID000024843 | |
| Drug | fluo-3 | 5.48e-04 | 122 | 30 | 3 | CID000104978 | |
| Drug | bepridil | 6.02e-04 | 126 | 30 | 3 | CID000002351 | |
| Drug | amlodipine | 6.02e-04 | 126 | 30 | 3 | CID000002162 | |
| Drug | NCDC | 6.21e-04 | 28 | 30 | 2 | CID000001583 | |
| Drug | clobazam | 6.67e-04 | 29 | 30 | 2 | CID000002789 | |
| Drug | Barium permanganate | 7.05e-04 | 133 | 30 | 3 | CID000024587 | |
| Drug | lanthanum | 7.52e-04 | 136 | 30 | 3 | CID000023926 | |
| Drug | K-Cl | 8.01e-04 | 567 | 30 | 5 | CID000004873 | |
| Drug | remifentanil | 8.12e-04 | 32 | 30 | 2 | CID000060814 | |
| Drug | isovalerate | 8.70e-04 | 143 | 30 | 3 | CID000010430 | |
| Drug | Dantrolene-13C3 | 9.06e-04 | 145 | 30 | 3 | CID000002951 | |
| Drug | nimodipine | 9.06e-04 | 145 | 30 | 3 | CID000004497 | |
| Drug | nicardipine | 9.06e-04 | 145 | 30 | 3 | CID000004473 | |
| Drug | Bay K 8644 | 9.99e-04 | 150 | 30 | 3 | CID000002303 | |
| Drug | procaine | 1.06e-03 | 153 | 30 | 3 | CID000004914 | |
| Drug | lindane | 1.08e-03 | 154 | 30 | 3 | CID000000727 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 3.41e-09 | 4 | 29 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 5.96e-06 | 36 | 29 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Sudden Cardiac Death | 2.60e-05 | 8 | 29 | 2 | C0085298 | |
| Disease | Manic Disorder | 4.66e-05 | 71 | 29 | 3 | C0024713 | |
| Disease | extrapulmonary tuberculosis | 6.12e-05 | 12 | 29 | 2 | MONDO_0000368 | |
| Disease | Manic | 6.18e-05 | 78 | 29 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 6.42e-05 | 79 | 29 | 3 | C0005587 | |
| Disease | insular cortex volume measurement | 2.33e-04 | 23 | 29 | 2 | EFO_0010309 | |
| Disease | resting heart rate | 4.19e-04 | 149 | 29 | 3 | EFO_0004351 | |
| Disease | pyridoxate measurement | 4.26e-04 | 31 | 29 | 2 | EFO_0010527 | |
| Disease | major depressive episode, major depressive disorder | 5.44e-04 | 35 | 29 | 2 | EFO_0007634, MONDO_0002009 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 7.84e-04 | 42 | 29 | 2 | DOID:612 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECFSAQKECNKEKNR | 1166 | P23470 | |
| LCYKNKDNQDKVNEL | 381 | Q9UBB4 | |
| ENYNAKCVEQERLKK | 141 | Q0JRZ9 | |
| CQCDKKKRRKQQYQQ | 561 | P20309 | |
| CIEKQERFCQLKKQN | 1151 | Q8N2N9 | |
| KDNDNCLDKCAQLRK | 276 | O43827 | |
| CIEKQERFCQLKKQN | 1576 | Q5JPF3 | |
| QEEYQIQQNCEKCHK | 76 | Q96IM9 | |
| CTQQKYLCTNKREQK | 1131 | Q8IVV2 | |
| QEQYAKEQARNKCKD | 1021 | Q9GZU2 | |
| EYKNCELDKNQRQCV | 1196 | Q13936 | |
| YKNCELDKNQRQCVQ | 1076 | Q13698 | |
| KNNKQNNEFCKCIET | 876 | Q8TF40 | |
| KNDYDQLQKARQCEK | 1136 | P15924 | |
| VRENKALQKKCADYQ | 941 | Q9BYX4 | |
| KEYKNCELDKNQRQC | 1161 | Q01668 | |
| DVCTKDRQCQDNKKC | 46 | O95925 | |
| QKCDDLQRNKCYQEV | 906 | Q96DN5 | |
| NAVEKEPCNLNKNCY | 1206 | Q9UPZ6 | |
| VENKEVYQCRLCNAK | 716 | Q9ULJ3 | |
| CENCTKNKQKYQEET | 641 | Q70EL2 | |
| QYNKEQLCLEKDKAR | 1336 | Q13129 | |
| KCKLDKSEENCNNLR | 591 | Q15431 | |
| EKQEQSYKCNKCVEV | 261 | Q14586 | |
| DCFKRECNNKLLKEN | 61 | Q9NVV9 | |
| LTQCQLECEKYQKKL | 481 | Q8WXW3 | |
| LQDKQRKIYCVACQE | 61 | O60232 | |
| ENQQKQYICSFEDCK | 126 | Q92664 | |
| NEYQEYEKQPCKCKA | 131 | P17017 | |
| QLQRKVDEQNKDYKC | 931 | Q9Y4I1 |